Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Venetoclax

EU orphan designation number: EU/3/16/1617   
Active ingredient: Venetoclax
Indication: Treatment of acute myeloid leukaemia
Sponsor: AbbVie Ltd
Abbvie House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire SL6 4UB, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/02/2016 Orphan designation EMA/OD/205/15 (2016)1110 of 17/02/2016